Metraipolis › archive › dc_0e146bc995c4

Sequential chemo-durvalumab, reduced-dose RT, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen (DEDALUS trial) — Europe PMC PMID:42093085

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42093085
DOI
10.1093/jncics/pkag050
License (as archived)
solo-consultazione
Archived
2026-11-02T20:35:24.663Z
SHA-256 of the archived text
2bcced209adccb137e4279923a8da71bbdcedc2e0702cd26a9bfa91175c3c98c
Stable URL of this page
https://metraipolis.com/documento/dc_0e146bc995c4

How to cite

Sequential chemo-durvalumab, reduced-dose RT, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen (DEDALUS trial) — Europe PMC PMID:42093085 — Europe PMC (en), https://europepmc.org/article/MED/42093085 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0e146bc995c4 (Metraipolis archive dc_0e146bc995c4, sha256 2bcced209adccb137e4279923a8da71bbdcedc2e0702cd26a9bfa91175c3c98c)
BibTeX
@misc{dc0e146bc995c4,
  title = {Sequential chemo-durvalumab, reduced-dose RT, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen (DEDALUS trial) — Europe PMC PMID:42093085},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42093085},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0e146bc995c4; sha256 2bcced209adccb137e4279923a8da71bbdcedc2e0702cd26a9bfa91175c3c98c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42093085. Agents can read the archived copy with the MCP tool read_document.